iShares Healthcare Innovation UCITS ETFiShares Healthcare Innovation UCITS ETFiShares Healthcare Innovation UCITS ETF

iShares Healthcare Innovation UCITS ETF

No trades
See on Supercharts

Key stats


Assets under management (AUM)
‪17.85 B‬MXN
Fund flows (1Y)
‪−3.93 B‬MXN
Dividend yield (indicated)
Discount/Premium to NAV
−2.2%
Shares outstanding
‪2.21 B‬
Expense ratio
0.40%

About iShares Healthcare Innovation UCITS ETF


Brand
iShares
Home page
Inception date
Sep 8, 2016
Structure
Irish VCIC
Index tracked
STOXX Global Breakthrough Healthcare (USD)(NR)
Replication method
Physical
Management style
Passive
Dividend treatment
Capitalizes
Primary advisor
BlackRock Asset Management Ireland Ltd.
ISIN
IE00BYZK4776
The investment objective of the Fund is to seek to provide investors with a total return, taking into account both capital and income returns, which reflects the return of the STOXX Global Breakthrough Healthcare Index

Classification


Asset Class
Equity
Category
Sector
Focus
Health care
Niche
Broad-based
Strategy
ESG
Geography
Global
Weighting scheme
Equal
Selection criteria
Principles-based

Returns


1 month3 monthsYear to date1 year3 years5 years
Price performance
NAV total return

What's in the fund


As of September 4, 2025
Exposure type
StocksBonds, Cash & Other
Health Technology
Stocks99.64%
Health Technology87.97%
Health Services4.37%
Commercial Services3.66%
Technology Services2.36%
Producer Manufacturing0.69%
Finance0.33%
Electronic Technology0.16%
Consumer Non-Durables0.11%
Bonds, Cash & Other0.36%
Cash0.36%
Mutual fund0.00%
Stock breakdown by region
1%63%24%10%
North America63.15%
Europe24.67%
Asia10.59%
Oceania1.59%
Latin America0.00%
Africa0.00%
Middle East0.00%
Top 10 holdings

Dividends


Dividend payout history

Assets under management (AUM)



Fund Flows



Frequently Asked Questions


HEAL/N invests in stocks. The fund's major sectors are Health Technology, with 87.97% stocks, and Health Services, with 4.37% of the basket. The assets are mostly located in the North America region.
HEAL/N top holdings are UCB S.A. and BeOne Medicines Ltd., occupying 1.98% and 1.95% of the portfolio correspondingly.
HEAL/N assets under management is ‪17.85 B‬ MXN. It's risen 5.74% over the last month.
HEAL/N fund flows account for ‪−3.93 B‬ MXN (1 year). Many traders use this metric to get insight into investors' sentiment and evaluate whether it's time to buy or sell the fund.
No, HEAL/N doesn't pay dividends to its holders.
HEAL/N shares are issued by BlackRock, Inc. under the brand iShares. The ETF was launched on Sep 8, 2016, and its management style is Passive.
HEAL/N expense ratio is 0.40% meaning you'd have to pay 0.40% of your investment to help manage the fund.
HEAL/N follows the STOXX Global Breakthrough Healthcare (USD)(NR). ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
HEAL/N invests in stocks.
HEAL/N price has risen by 2.72% over the last month, and its yearly performance shows a −5.33% decrease. See more dynamics on HEAL/N price chart.
NAV returns, another gauge of an ETF dynamics, showed a 6.05% increase in three-month performance and has decreased by −2.67% in a year.
HEAL/N trades at a premium (2.19%) meaning the ETF is trading at a higher price than the calculated NAV.